Aroa Biosurgery (ASX:ARX) Interest Expense : A$-1.16 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aroa Biosurgery's interest expense for the six months ended in Mar. 2024 was A$ 0.82 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was A$-1.16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aroa Biosurgery's Operating Income for the six months ended in Mar. 2024 was A$ -6.53 Mil. Aroa Biosurgery's Interest Expense for the six months ended in Mar. 2024 was A$ 0.82 Mil. Aroa Biosurgery did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aroa Biosurgery Interest Expense Historical Data

The historical data trend for Aroa Biosurgery's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Interest Expense Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

-1.38

-0.70

-0.01

-1.16

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Interest Expense	Get a 7-Day Free Trial			0.12	-1.26	1.25	-1.98	0.82

Aroa Biosurgery Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-1.16 Mil.

Aroa Biosurgery (ASX:ARX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aroa Biosurgery's Interest Expense for the six months ended in Mar. 2024 was A$0.82 Mil. Its Operating Income for the six months ended in Mar. 2024 was A$-6.53 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2024 was A$5.90 Mil.

Aroa Biosurgery's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines